CJC-1295 + Ipamorelin
Reviewed
Verified
Free
Packed
CJC-1295 + Ipamorelin
Compounded Subcutaneous Injectable — Provider-Directed Dosing Protocol
CJC-1295 and Ipamorelin are growth hormone secretagogues that have been studied together for their complementary mechanisms in stimulating growth hormone release. CJC-1295 is a GHRH (growth hormone releasing hormone) analog; Ipamorelin is a selective GHRP (growth hormone releasing peptide). Research has examined this combination for its role in pulsatile growth hormone secretion. Treatment decisions are made by licensed providers following a clinical evaluation.
- ✓ Dual-mechanism combination — GHRH analog + selective GHRP studied together
- ✓ Studied for their role in supporting natural pulsatile growth hormone signaling
- ✓ Subcutaneous injection — provider-directed dosing and titration
- ✓ Compounded in an FDA-registered 503A pharmacy
- ✓ Provider evaluation included — clinical review before every prescription
Intro pricing — locked in for active program participants
- ✓ 4-week supply · dosage set by your provider
- ✓ Bacteriostatic water for reconstitution
- ✓ Syringes & alcohol swabs
- ✓ Free cold-pack shipping
- ✓ Ongoing provider oversight & prescription management
- ✓ Medication fulfilled if prescribed
Your provider may authorize multiple refills as part of your treatment plan. Refills and treatment continuation are determined by your licensed provider.
Treatment decisions are made by licensed medical providers following a clinical review. Results vary and no outcomes are guaranteed.
Start My Evaluation →The dual secretagogue mechanism — how researchers are studying it
CJC-1295 and Ipamorelin work through different but complementary receptor pathways — studied together for their combined effect on growth hormone signaling.
CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH). It has been studied for its role in binding pituitary GHRH receptors and stimulating growth hormone release. Its extended half-life has been a focus of research compared to native GHRH.
Ipamorelin is a selective growth hormone secretagogue studied for its activity at ghrelin receptors. Research has examined its selectivity profile — including its studied effect of stimulating GH release with minimal influence on cortisol and prolactin compared to other GHRPs.
The combination of CJC-1295 and Ipamorelin engages two distinct receptor pathways simultaneously. Research has examined this dual-pathway approach for its potential to produce a more pronounced pulsatile GH release compared to either compound studied alone.
The combination of GHRH analogs and GHRPs has been the subject of published clinical research. Treatment decisions involving these compounds are made by licensed providers based on individual health evaluations.
How it works
From your first inquiry to an active treatment plan — here’s the process.
Answer a short health questionnaire. Takes under 5 minutes. Fully HIPAA-compliant. Your provider uses this to evaluate candidacy.
A licensed provider reviews your health profile and determines whether this treatment is appropriate for your individual situation — usually same day.
If prescribed, your kit ships from our FDA-registered pharmacy, cold-packed and discreetly packaged. Ships within 24 hours of provider approval.
Your provider sets the dosing schedule. Self-administered at home. Support team available throughout your program.
What’s in your kit
Everything included for your provider-directed protocol. Nothing unnecessary.
Compounded CJC-1295 + Ipamorelin in your provider-determined dosage, formulated at an FDA-registered 503A pharmacy.
For reconstituting your lyophilized peptide. Included and pre-measured for your kit.
4-week supply of 1mL insulin syringes. Ready to use, no extra equipment needed.
Individually wrapped prep swabs for site sterilization before each injection.
Provider-issued protocol card with injection guidance and dosing schedule specific to your prescription.
Questions? Our support team is available 7 days a week. Treatment program participants get priority response.
Quality Control
Every API tested 5 ways before it touches a vial.
The active pharmaceutical ingredients in your medication are tested at the API level — before compounding — across five independent quality markers.
Confirms you’re getting exactly the dose on the label. No underdosed vials.
Zero microbial contamination. Required for anything injected into the body.
Tests for bacterial byproducts that cause dangerous inflammatory responses.
Ensures the compound is stable and safe at the correct physiological pH.
Verifies there are no foreign substances, degradants, or unknown compounds present.
Member experiences.
Verified participants sharing their experience with the process and their provider-directed program.
“The intake process was more thorough than any telehealth platform I’ve used. My provider reviewed my history carefully and explained the protocol before approving. Kit arrived cold-packed in two days. Two months in and the provider check-ins have been consistent throughout.”
“I researched this combo extensively before starting. What sold me was the FDA-registered pharmacy and the fact that a real provider reviews everything — not an algorithm. Process was professional from intake to delivery.”
“My provider adjusted my starting dose based on my blood panel — not a cookie-cutter protocol. That personalized approach is exactly what I was looking for. Support team has been responsive whenever I have questions.”
What to expect
Every protocol works on its own timeline. Your provider will set expectations specific to your prescription.
Body begins responding. Provider sets a conservative starting dose. Mild adjustment effects possible.
Provider monitors response and may adjust dosing based on tolerance and individual response.
Provider reassesses and adjusts the protocol based on your progress and clinical response.
Treatment continuation is determined by your licensed provider based on clinical evaluation.
Before you begin
A few things to know so you’re set up for a safe, provider-guided experience.
Administer only as directed by your provider. Your provider instructions will include guidance specific to your protocol — do not deviate from the prescribed schedule.
Store your vials refrigerated (36–46°F). Do not freeze. Keep out of direct light. Follow any specific storage instructions included with your kit.
Never mix with other medications in the same syringe. If you experience unexpected side effects, hold your dose and contact your provider before continuing.
Contact your provider or our support team before adjusting your protocol. Never self-escalate dosing without provider authorization.
Individual responses vary. Your provider will set timeline expectations specific to your prescription and health profile. Results are not guaranteed.
Your dosage is determined by your provider after reviewing your intake. You will not know your starting dose until after provider approval.
Is this right for you?
Candidacy is determined by your licensed provider after reviewing your health profile. These are general guidelines — your provider makes the final determination.
✅ May be a candidate if you…
- → Are interested in growth hormone research and provider-directed treatment programs
- → Have undergone or are open to a licensed provider evaluation
- → Are committed to following a provider-directed protocol
- → Are not pregnant or breastfeeding
- → Have no contraindicated conditions (determined at intake)
- → Are in one of our currently served states
❌ Likely not a candidate if you…
- → Are currently pregnant or planning to become pregnant
- → Have an active or history of malignancy (provider will screen)
- → Have known pituitary disease or dysfunction
- → Are under 18 years of age
- → Are outside our currently served states
- → Are unwilling to complete a full provider intake evaluation
Member reviews
4.8 out of 5 — based on 112 verified purchases
112 verified reviews
My provider didn’t rubber-stamp my intake — they asked follow-up questions about my bloodwork and adjusted my starting protocol. That level of real clinical engagement is rare for an online platform. Two months in and everything has been exactly as described.
✓ Verified PurchaseI was skeptical of online peptide platforms but the FDA-registered pharmacy was non-negotiable for me and HumanPeptide checked that box. Kit arrived cold-packed with clear instructions. Support team has been responsive throughout.
✓ Verified PurchaseMinor injection site sensitivity the first week that resolved quickly. My provider walked me through it and we made a small adjustment. After that, completely smooth. The access to my provider was better than I expected from an online service.
✓ Verified PurchaseThe difference between HumanPeptide and other platforms is the actual provider involvement. Real questions, real follow-ups, real adjustments. The pharmacy credentials are verified and the process is exactly as professional as advertised.
✓ Verified PurchaseFrequently asked questions
Straight answers. No fluff.
CJC-1295 and Ipamorelin are growth hormone secretagogues — compounds studied for their role in stimulating growth hormone release through distinct receptor pathways. CJC-1295 is a GHRH analog; Ipamorelin is a selective GHRP. They are studied in combination for their complementary mechanisms. Treatment decisions involving these compounds are made by licensed providers following a thorough clinical evaluation.
Neither CJC-1295 nor Ipamorelin is currently FDA-approved. They are available as compounded medications through licensed providers and FDA-registered 503A compounding pharmacies. Treatment decisions are made at the discretion of a licensed healthcare provider following a clinical review of your individual health profile.
Yes. This medication requires a prescription from a licensed provider. After completing your intake form, a provider reviews your health profile and determines whether this treatment is appropriate. If approved, the prescription is filled by our compounding pharmacy. No office visit required.
We currently serve: Florida, Rhode Island, Missouri, Wisconsin, Montana, Arizona, Vermont, Virginia, Wyoming, South Dakota, New York, Georgia, and New Mexico. We’re expanding — check back if your state isn’t listed.
Your provider may authorize a multi-month prescription as part of your treatment plan. When a multi-month prescription is issued, your program is billed monthly and medication is fulfilled for each billing period — no new provider approval is required until the prescription expires. Refills and treatment continuation are always determined by your licensed provider.
Cancel anytime before your next billing cycle — no fees, no phone calls. Log into your account and cancel in one click, or contact our support team and we’ll handle it immediately. Cancellation must be submitted at least 72 hours before your billing date.
Potential side effects vary by individual and are reviewed by your provider at intake. Your provider will set expectations and monitoring guidance specific to your protocol. Contact your provider or our support team if you experience unexpected symptoms.
Not at this time. FSA/HSA eligibility is on our roadmap and we’ll notify members when it becomes available.
⚠️ Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. CJC-1295 and Ipamorelin are not FDA-approved and are available only through licensed healthcare providers via FDA-registered 503A compounding pharmacies. Treatment decisions are made by licensed medical providers following a clinical review. Results vary and no outcomes are guaranteed. HumanPeptide.com is not a licensed medical provider. Always consult your physician before starting any new medication or treatment protocol. This product has not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease.
Ready to explore your treatment options?
Complete your intake and a licensed provider will review your profile — usually same day.
Start My Evaluation →